Putting Humpty Dumpty Back Together Again

Corbis For 50 years, biologists have focused on reducing life to its constituent parts, first focusing on the cell, then working their way down to the genome itself. However, such achievements created a new challenge--making sense of the huge amounts of data produced. As professor Denis Noble, Oxford University, puts it: "It took Humpty Dumpty apart but left the challenge of putting him back together again." Systems biology attempts to reconstruct Humpty Dumpty as a series of overlapping math

Written byPhilip Hunter
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

For 50 years, biologists have focused on reducing life to its constituent parts, first focusing on the cell, then working their way down to the genome itself. However, such achievements created a new challenge--making sense of the huge amounts of data produced. As professor Denis Noble, Oxford University, puts it: "It took Humpty Dumpty apart but left the challenge of putting him back together again."

Systems biology attempts to reconstruct Humpty Dumpty as a series of overlapping mathematical models. It exploits all the theoretical and experimental advances of the various genome projects, allying them to computational, mathematical and engineering disciplines in an attempt to create predictive models of cells, organs, biochemical processes, and complete organisms. It has the potential to unravel how complex biochemical systems, from cells to organisms, really work, and to take a leap forward in preventing and treating disease. "Diseases ... are often a fault of a ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies